XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (850,000) $ 6,174,000
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:    
Purchase of marketable securities (101,913,000) (101,040,000)
Proceeds from sale and maturity of marketable securities 100,705,000 99,638,000
Change in value of marketable securities 5,068,000 (4,445,000)
Deferred and other income taxes (1,177,000) 457,000
Depreciation and amortization 2,063,000 1,931,000
Provision for doubtful accounts 140,000 125,000
Changes in assets and liabilities, excluding the initial effects of business acquisitions:    
Accounts receivable (1,716,000) (1,253,000)
Costs and estimated earnings in excess of billings 537,000 7,090,000
Inventories (6,356,000) (3,357,000)
Prepaid expenses and other current assets (1,518,000) (44,000)
Accounts payable 1,896,000 2,678,000
Customer deposits 2,192,000 (92,000)
Accrued expenses and other current liabilities (645,000) 268,000
Total adjustments (724,000) 1,956,000
Cash flows (used in) provided by operating activities (1,574,000) 8,130,000
Cash flows from investing activities:    
Acquisition of Blaw-Knox assets   (13,777,000)
Capital expenditures (2,184,000) (2,449,000)
Cash flows used in investing activities (2,184,000) (16,226,000)
Cash flows from financing activities:    
Proceeds from stock option exercises   56,000
Cash flows provided by financing activities   56,000
Net decrease in cash and cash equivalents (3,758,000) (8,040,000)
Cash and cash equivalents at:    
Beginning of period 23,232,000 35,584,000
End of period $ 19,474,000 27,544,000
Non-cash investing and financing activities:    
Operating lease right-of-use assets   254,000
Operating lease liabilities   $ 254,000